Meeting Report: Funding rises for early assets Interviewee/Contributor Søren Møller Organisation Novo Seeds Antibiotics Drug discovery Venture Capital drug-resistant pathogens Read more about Meeting Report: Funding rises for early assets
Why invest in the US, when Europe beckons? Interviewee/Contributor Stephan Christgau Organisation Novo Seeds Finance Strategy Read more about Why invest in the US, when Europe beckons?